Cargando…
Prognostic Impact of LAG-3 mRNA Expression in Early Breast Cancer
Background: Monoclonal antibodies against PD-1 or PD-L1 have been established in clinical practice for the treatment of both early and advanced/metastatic triple-negative breast cancer. Beyond the established immune checkpoints (ICPs) (PD-1 and CTLA-4), additional ICPs, such as lymphocyte activation...
Autores principales: | Heimes, Anne-Sophie, Almstedt, Katrin, Krajnak, Slavomir, Runkel, Anne, Droste, Annika, Schwab, Roxana, Stewen, Kathrin, Lebrecht, Antje, Battista, Marco J., Brenner, Walburgis, Hasenburg, Annette, Gehrmann, Mathias, Hengstler, Jan G., Schmidt, Marcus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599264/ https://www.ncbi.nlm.nih.gov/pubmed/36289918 http://dx.doi.org/10.3390/biomedicines10102656 |
Ejemplares similares
-
Prognostic Impact of CD38- and IgκC-Positive Tumor-Infiltrating Plasma Cells in Triple-Negative Breast Cancer
por: Heimes, Anne-Sophie, et al.
Publicado: (2023) -
Prognostic Significance of Interferon-γ and Its Signaling Pathway in Early Breast Cancer Depends on the Molecular Subtypes
por: Heimes, Anne-Sophie, et al.
Publicado: (2020) -
Discordance of HER2-Low between Primary Tumors and Matched Distant Metastases in Breast Cancer
por: Almstedt, Katrin, et al.
Publicado: (2023) -
Prognostic Impact of Immunoglobulin Kappa C (IGKC) in Early Breast Cancer
por: Schmidt, Marcus, et al.
Publicado: (2021) -
Patients’ expectations of preventive measures of medical institutions during the SARS-CoV-2 pandemic in Germany in women with an increased risk of breast and ovarian cancer: a cross-sectional, web-based survey
por: Schwab, Roxana, et al.
Publicado: (2022)